Drugs & Side Effects |

Cholestreol Drugs News

Study on Raising Good Cholesterol to Begin

RSS News Feeds
Drugs & Pharmacuticals
Cholestreol Drugs
Baycol
Lipitor
 All RSS Feeds

At a glance:

A major study run by Oxford University in England is set to begin, which will study the effect on heart disease of a new drug combination. 
 
The treatment aims to raise levels of "good" cholesterol (HDL) in the body. This can be accomplished with the vitamin niacin, but with unpleasant side effects (facial flushing) so another new drug has been added to minimize the side effects. 
 
The aim is to further reduce the risk of heart attack and stroke in people already being treated for high cholesterol. Current cholesterol drugs (statins) only lower the "bad" cholesterol (LDL).

Oxford University launches major cardiovascular drug study

MarketWatch - 5/31/2006 7:33 AM

LONDON (MarketWatch) -- Oxford University's Clinical Trial Service Unit said Wednesday that it is launching a major international study to test a new drug combination to reduce cardiovascular disease.
 
The study - to test whether a combination treatment that increases good "HDL" cholesterol prevents heart attacks and strokes - will start to recruit patients later this year.
 
· Read The Full Cholestreol Drugs Article From MarketWatch -->

· Read All Statin, Lipid & Cholestreol Drugs News Stories -->

Comments On Cholestreol Drugs News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: